BiotechTube
Home/Aquinnah Pharmaceuticals/Dr. Ben Wolozin
DB

Dr. Ben Wolozin

Co-founder and Chief Scientific Officer

Aquinnah Pharmaceuticals

Therapeutic Areas

Alzheimer's DiseaseAmyotrophic Lateral Sclerosis (ALS)Neurodegenerative Diseases

Aquinnah Pharmaceuticals Pipeline

DrugIndicationPhase
Undisclosed Small MoleculeAlzheimer's DiseasePreclinical

Leadership Team at Aquinnah Pharmaceuticals

DG
Dr. Glenn Larsen
Co-founder, President and CEO
BC
Bob Carpenter
Board Member
View full Aquinnah Pharmaceuticals profile